Cited by 473Global Cancer Incidence and ScreeningCancer Genomics and DiagnosticsCancer Diagnosis and Treatment

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: Toward Strengthening the Critical Relationship

Open access

Duggan, Máire A., Anderson, William F., Altekruse, Sean, Penberthy, Lynne, Sherman, Mark E.·2016·American Journal of Surgical Pathology

DOI 10.1097/pas.0000000000000749PMC PMC5106320

Open this paper in CoChat — free account

Abstract

The Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute collects data on cancer diagnoses, treatment, and survival for approximately 30% of the United States (US) population. To reflect advances in research and oncology practice, approaches to cancer control are evolving from simply enumerating the development of cancers by organ site in populations to including monitoring of cancer occurrence by histopathologic and molecular subtype, as defined by driver mutations and other alterations. SEER is an important population-based resource for understanding the implications of pathology diagnoses across demographic groups, geographic regions, and time and provides unique insights into the practice of oncology in the US that are not attainable from other sources. It provides incidence, survival, and mortality data for histopathologic cancer subtypes, and data by molecular subtyping are expanding. The program is developing systems to capture additional biomarker data, results from special populations, and expand biospecimen banking to enable cutting-edge cancer research and oncology practice. Pathology has always been central and critical to the effectiveness of SEER, and strengthening this relationship in this modern era of cancer diagnosis could be mutually beneficial. Achieving this goal requires close interactions between pathologists and the SEER program. This review provides a brief overview of SEER, focuses on facets relevant to pathology practice and research, and highlights the opportunities and challenges for pathologists to benefit from and enhance the value of SEER data.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1097/pas.0000000000000749

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Swerdlow, S. H., Campo, E., Pileri, S. A., Harris, N. L., Stein, H., Siebert, R., Advani, R., Ghielmini, M., Salles, G. A., Zelenetz, A. D., et al. (2016) · Blood · doi:10.1182/blood-2016-01-643569 · Cited by 7,831
Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually
Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334
US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
Howlader, N., Altekruse, S. F., Li, C. I., Chen, V. W., Clarke, C. A., Ries, L. A. G., & Cronin, K. A. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju055 · Cited by 1,572
Self-citation
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J.-S., Squire, J., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318290868f · Cited by 1,280
The Decrease in Breast-Cancer Incidence in 2003 in the United States
Ravdin, P. M., Cronin, K. A., Howlader, N., Berg, C. D., Chlebowski, R. T., Feuer, E. J., Edwards, B. K., & Berry, D. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr070105 · Cited by 981
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors
Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Đačić, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J., Squire, J. A., et al. (2013) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.03.001 · Cited by 461
Racial Disparities in Cancer Survival Among Randomized Clinical Trials Patients of the Southwest Oncology Group
Albain, K. S., Unger, J. M., Crowley, J. J., Coltman, C. A., & Hershman, D. L. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp175 · Cited by 458
Cervical Cancer Trends in the United States: A 35-Year Population-Based Analysis
Adegoke, O. O., Kulasingam, S., & Virnig, B. A. (2012) · Journal of Women s Health · doi:10.1089/jwh.2011.3385 · Cited by 353
Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002
Criscione, V. D., & Weinstock, M. A. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.09.006 · Cited by 350
Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy
Beral, V., REEVES, G. K., Bull, D., Green, J., & Collaborators, F. T. M. W. S. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq527 · Cited by 290

Show all 46 references

Sorted by citations

Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma
Zhou, Y., Yang, D., Yang, Q., Lv, X., Huang, W., Zhou, Z., Wang, Y., Zhang, Z., Yuan, T., Ding, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20059-6 · Cited by 672
Annual Report to the Nation on the Status of Cancer, Featuring Cancer in Men and Women Age 20–49 Years
Ward, E., Sherman, R., Henley, S. J., Jemal, A., Siegel, D. A., Feuer, E. J., Firth, A. U., Kohler, B., Scott, S., Ma, J., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz106 · Cited by 324
Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis
Blackford, A. L., Canto, M. I., Klein, A. P., Hruban, R. H., & Goggins, M. (2020) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djaa004 · Cited by 270
Tractor uses local ancestry to enable the inclusion of admixed individuals in GWAS and to boost power
Atkinson, E. G., Maihofer, A. X., Kanai, M., Martin, A. R., Karczewski, K. J., Santoro, M. L., Ulirsch, J. C., Kamatani, Y., Okada, Y., Finucane, H. K., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00766-y · Cited by 239
The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p/CARM1 axis
Zhang, L.-X., Gao, J., Long, X., Zhang, P., Yang, X., Zhu, S., Pei, X., Qiu, B., Chen, S., Lü, F., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01586-w · Cited by 149
How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology
Che, W., Li, Y.-J., Tsang, C. K., Wang, Y., Chen, Z., Wang, X., Xu, A.-D., & Lyu, J. (2023) · Military Medical Research · doi:10.1186/s40779-023-00488-2 · Cited by 148
Emerging roles of gap junction proteins connexins in cancer metastasis, chemoresistance and clinical application
Wu, J.-I., & Wang, L. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0497-x · Cited by 128
Epidemiology of Signet Ring Cell Adenocarcinomas
Benesch, M. G. K., & Mathieson, A. (2020) · Cancers · doi:10.3390/cancers12061544 · Cited by 123
Strategies to overcome acquired resistance to EGFR TKI in the treatment of non-small cell lung cancer
Gao, J., Li, H.-R., Jin, C., Jiang, J., & Ding, J. (2019) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02075-1 · Cited by 113
Contributions of Adenocarcinoma and Carcinoid Tumors to Early-Onset Colorectal Cancer Incidence Rates in the United States
Montminy, E. M., Zhou, M., Maniscalco, L. S., Abualkhair, W. H., Kim, M. K., Siegel, R. L., Wu, X., Itzkowitz, S. H., & Karlitz, J. J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0068 · Cited by 104
Epidemiology and Outcomes of Young-Onset Esophageal Adenocarcinoma: An Analysis from a Population-Based Database
Codipilly, D. C., Sawas, T., Dhaliwal, L. S., Johnson, M. L., Lansing, R. L., Wang, K. K., Leggett, C. L., Katzka, D. A., & Iyer, P. G. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0944 · Cited by 98
Epidemiology of synchronous brain metastases
Singh, R. B., Stoltzfus, K. C., Chen, H., Louie, A. V., Lehrer, E. J., Horn, S. R., Palmer, J. D., Trifiletti, D. M., Brown, P. D., & Zaorsky, N. G. (2020) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaa041 · Cited by 94
Epidemiology of the classical myeloproliferative neoplasms: The four corners of an expansive and complex map
Shallis, R. M., Wang, R., Davidoff, A. J., Ma, X., Podoltsev, N. A., & Zeidan, A. M. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100706 · Cited by 91
Differences in the incidence and mortality of digestive cancer between Global Cancer Observatory 2020 and Global Burden of Disease 2019
Yu, Z., Bai, X., Zhou, R., Ruan, G., Guo, M., Han, W., Jiang, S., & Yang, H. B. (2023) · International Journal of Cancer · doi:10.1002/ijc.34740 · Cited by 84
Effects of marital status on breast cancer survival by age, race, and hormone receptor status: A population‐based Study
Zhai, Z., Zhang, F., Zheng, Y., Zhou, L., Tian, T., Lin, S., Deng, Y., Xu, P., Hao, Q., Li, N., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2352 · Cited by 79
Crabp2 Promotes Metastasis of Lung Cancer Cells via HuR and Integrin β1/FAK/ERK Signaling
Wu, J.-I., Lin, Y., Tseng, C.-W., Chen, H.-J., & Wang, L. (2019) · Scientific Reports · doi:10.1038/s41598-018-37443-4 · Cited by 78
The National Cancer Database Conforms to the Standardized Framework for Registry and Data Quality
Palis, B. E., Janczewski, L. M., Browner, A. E., Cotler, J. H., Nogueira, L., Richardson, L. C., Benard, V. B., Wilson, R. J., Walker, N., McCabe, R. M., et al. (2024) · Annals of Surgical Oncology · doi:10.1245/s10434-024-15393-8 · Cited by 74
The Proteomic Landscape of Pancreatic Ductal Adenocarcinoma Liver Metastases Identifies Molecular Subtypes and Associations with Clinical Response
Law, H. C.-H., Lagundžin, D., Clement, E. J., Qiao, F., Wagner, Z. S., Krieger, K. L., Costanzo-Garvey, D. L., Caffrey, T. C., Grem, J. L., DiMaio, D. J., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1496 · Cited by 71
Information quality of videos related to esophageal cancer on tiktok, kwai, and bilibili: a cross-sectional study
Zhu, W., He, B., Wang, X., Du, Y., Young, K., & Jiang, S. (2025) · BMC Public Health · doi:10.1186/s12889-025-23475-9 · Cited by 74
The association between race and survival in glioblastoma patients in the US: A retrospective cohort study
Bohn, A., Braley, A. E., de la Vega, P. R., Zevallos, J. C., & Barengo, N. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198581 · Cited by 67
Stark differences in cancer epidemiological data between GLOBOCAN and GBD: Emphasis on oral cancer and wider implications
Fan, K. M., Rimal, J., Zhang, P., & Johnson, N. W. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101673 · Cited by 65
Evaluating Travel Distance to Radiation Facilities Among Rural and Urban Breast Cancer Patients in the Medicare Population
Longacre, C. F., Neprash, H. T., Shippee, N. D., Tuttle, T. M., & Virnig, B. A. (2019) · The Journal of Rural Health · doi:10.1111/jrh.12413 · Cited by 63
Laminarin-Derived from Brown Algae Suppresses the Growth of Ovarian Cancer Cells via Mitochondrial Dysfunction and ER Stress
Bae, H., Song, G., Lee, J., Hong, T., Chang, M., & Lim, W. (2020) · Marine Drugs · doi:10.3390/md18030152 · Cited by 61
Disruption of Endoplasmic Reticulum and ROS Production in Human Ovarian Cancer by Campesterol
Bae, H., Park, S., Yang, C., Song, G., & Lim, W. (2021) · Antioxidants · doi:10.3390/antiox10030379 · Cited by 65
Dynamic changes in marital status and survival in women with breast cancer: a population-based study
Ding, W., Ruan, G., Lin, Y.-L., Zhu, J., Tu, C., & Li, Z. (2021) · Scientific Reports · doi:10.1038/s41598-021-84996-y · Cited by 55
Marital status is an independent prognostic factor in inflammatory breast cancer patients: an analysis of the surveillance, epidemiology, and end results database
Liu, Y., Wang, D.-W., Yang, Z.-C., Ma, R., Zhong, L., Wei, S., Zhao, Z., & Li, Z. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05385-8 · Cited by 55
The survival of esophageal cancer by subtype in China with comparison to the United States
An, L., Zheng, R., Zeng, H., Zhang, S., Chen, R., Wang, S., Sun, K., Li, L., Wei, W., & He, J. (2022) · International Journal of Cancer · doi:10.1002/ijc.34232 · Cited by 51
Early-Onset Colorectal Cancer in Patients under 50 Years of Age: Demographics, Disease Characteristics, and Survival
McClelland, P. H.-T., Liu, T., & Özüner, G. (2021) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2021.11.003 · Cited by 46
Unified fair federated learning for digital healthcare
Zhang, F., Shuai, Z., Kuang, K., Wu, F. Q., Zhuang, Y., & Xiao, J. (2023) · Patterns · doi:10.1016/j.patter.2023.100907 · Cited by 46
Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn’s Disease and 4 Years in Ulcerative Colitis
Ghosh, S. K., Feagan, B. G., Ott, E., Gasink, C., Godwin, B. C., Marano, C. W., Ye, M., Ma, T., Loftus, E. V., Sandborn, W. J., et al. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae013 · Cited by 46
Epidemiology and Survival Outcomes in Stages II and III Cutaneous Melanoma: A Systematic Review
Miller, R., Walker, S. L. M., Shui, I. M., Brandtmuller, A., Cadwell, K. K., & Scherrer, E. (2020) · Melanoma Management · doi:10.2217/mmt-2019-0022 · Cited by 46
Mixture Cure Models in Oncology: A Tutorial and Practical Guidance
Felizzi, F., Paracha, N., Pöhlmann, J., & Ray, J. A. (2021) · PharmacoEconomics - Open · doi:10.1007/s41669-021-00260-z · Cited by 46
Epidemiology of Mucinous Adenocarcinomas
Benesch, M. G. K., & Mathieson, A. (2020) · Cancers · doi:10.3390/cancers12113193 · Cited by 46
Osteosarcoma Cell‐Derived Migrasomes Promote Macrophage M2 Polarization to Aggravate Osteosarcoma Proliferation and Metastasis
Liu, W., Li, L., Bai, X., Zhang, M., Lv, W., Ma, Y., Sun, Y., Zhang, H., Jiang, Q., Yao, Q., et al. (2025) · Advanced Science · doi:10.1002/advs.202409870 · Cited by 46
Elastography Can Map the Local Inverse Relationship between Shear Modulus and Drug Delivery within the Pancreatic Ductal Adenocarcinoma Microenvironment
Wang, H., Mislati, R., Ahmed, R., Vincent, P., Nwabunwanne, S. F., Gunn, J. R., Pogue, B. W., & Doyley, M. M. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2684 · Cited by 43
Persistent opioid use is associated with worse survival after lobectomy for stage I non-small cell lung cancer
Nelson, D. B., Cata, J. P., Niu, J., Mitchell, K. G., Vaporciyan, A. A., Antonoff, M. B., Hofstetter, W. L., Giordano, S. H., Sepesi, B., Mehran, R. J., et al. (2019) · Pain · doi:10.1097/j.pain.0000000000001630 · Cited by 43
A Comparative Analysis of Deep Learning Approaches for Predicting Breast Cancer Survivability
Gupta, S., & Gupta, M. K. (2021) · Archives of Computational Methods in Engineering · doi:10.1007/s11831-021-09679-3 · Cited by 44
Incidence of radiation induced sarcoma attributable to radiotherapy in adults: A retrospective cohort study in the SEER cancer registries across 17 primary tumor sites
Snow, A. E., Ring, A., Struycken, L., Mack, W. J., Koç, M., & Lang, J. E. (2020) · Cancer Epidemiology · doi:10.1016/j.canep.2020.101857 · Cited by 41
Trends of Ovarian Cancer Incidence by Histotype and Race/Ethnicity in the United States 1992–2019
Phung, M. T., Pearce, C. L., Meza, R., & Jeon, J. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0410 · Cited by 39
Circulating microRNAs as potential diagnostic biomarkers and therapeutic targets in prostate cancer: Current status and future perspectives
Movahedpour, A., Ahmadi, N., Ghasemi, Y., Savardashtaki, A., & Shabaninejad, Z. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29053 · Cited by 40
Trends in Esophageal Cancer Mortality and Stage at Diagnosis by Race and Ethnicity in the United States
Corona, E., Yang, L., Esrailian, E., Ghassemi, K. A., Conklin, J. L., & May, F. P. (2021) · Cancer Causes & Control · doi:10.1007/s10552-021-01443-z · Cited by 38
Development and Validation of Prognostic Models for Oral Squamous Cell Carcinoma: A Systematic Review and Appraisal of the Literature
Russo, D., Mariani, P., Caponio, V. C. A., Russo, L. L., Fiorillo, L., Zhurakivska, K., Muzio, L. L., Laino, L., & Troiano, G. (2021) · Cancers · doi:10.3390/cancers13225755 · Cited by 37
Nomogram for predicting the survival of patients with malignant melanoma: A population analysis
Yang, J., Pan, Z., Zhou, Q., Liu, Q., Zhao, F., Feng, X., & Lyu, J. (2019) · Oncology Letters · doi:10.3892/ol.2019.10720 · Cited by 36
Mortality-to-incidence ratios by US Congressional District: Implications for epidemiologic, dissemination and implementation research, and public health policy
Eberth, J. M., Zahnd, W. E., Adams, S. A., Friedman, D. B., Wheeler, S. B., & Hébert, J. R. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.105849 · Cited by 35
An automated and mobile magnetoresistive biosensor system for early hepatocellular carcinoma diagnosis
Yao, C., Ng, E., & Wang, S. X. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.113982 · Cited by 35
The role of socioeconomic disparity in colorectal cancer stage at presentation
Patel, A. D., Gantz, O. B., Zagadailov, P., & Merchant, A. M. (2019) · Updates in Surgery · doi:10.1007/s13304-019-00632-5 · Cited by 34
Clinicopathological characteristics, treatment and survival of pulmonary large cell neuroendocrine carcinoma: a SEER population-based study
Cao, L., Li, Z., Wang, M., Zhang, T., Bao, B., & Liu, Y. (2019) · PeerJ · doi:10.7717/peerj.6539 · Cited by 34
Epithelioid sarcoma: half a century later
Elsamna, S. T., Amer, K. M., Elkattawy, O., & Beebe, K. S. (2019) · Acta Oncologica · doi:10.1080/0284186x.2019.1659514 · Cited by 34
Secondary databases in gynecologic cancer research
Hicks-Courant, K., Ko, E. M., Matsuo, K., Melamed, A., Nasioudis, D., Rauh‐Hain, J. A., Uppal, S., Wright, J. D., & Ramirez, P. T. (2024) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2024-005677 · Cited by 33
Travel, Treatment Choice, and Survival Among Breast Cancer Patients: A Population-Based Analysis
Longacre, C. F., Neprash, H. T., Shippee, N. D., Tuttle, T. M., & Virnig, B. A. (2021) · Women s Health Reports · doi:10.1089/whr.2020.0094 · Cited by 35
A population-based study on incidence trends of myeloma in the United States over 2000–2020
Mousavi, S. E., Ilaghi, M., Aslani, A., Yekta, Z., & Nejadghaderi, S. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-47906-y · Cited by 32
Elevated Interleukin-6 Levels in the Circulation and Peritoneal Fluid of Patients with Ovarian Cancer as a Potential Diagnostic Biomarker: A Systematic Review and Meta-Analysis
Amer, H., Kartikasari, A. E. R., & Plebanski, M. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11121335 · Cited by 34
Development of a machine learning-based model to predict prognosis of alpha-fetoprotein-positive hepatocellular carcinoma
Dong, B., Zhang, H., Duan, Y., Yao, S., Chen, Y., & Zhang, C. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05203-w · Cited by 36
National patterns of care and cancer-specific outcomes of adjuvant treatment in patients with serous and clear cell endometrial carcinoma
Xiang, M. H., English, D. P.-G., & Kidd, E. A. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.12.007 · Cited by 31
Gjb4 serves as a novel biomarker for lung cancer and promotes metastasis and chemoresistance via Src activation
Lin, Y., Wu, J.-I., Tseng, C.-W., Chen, H.-J., & Wang, L. (2018) · Oncogene · doi:10.1038/s41388-018-0471-1 · Cited by 30
Construction and validation of a nomogram to predict overall survival in patients with inflammatory breast cancer
Diao, J., Ma, L., Sun, M., Wu, C., Wang, L., Liu, Y., & Yang, Y. (2019) · Cancer Medicine · doi:10.1002/cam4.2470 · Cited by 29
Competing‐risks model for predicting the prognosis of penile cancer based on the SEER database
Yang, J., Pan, Z., He, Y., Zhao, F., Feng, X., Liu, Q., & Lyu, J. (2019) · Cancer Medicine · doi:10.1002/cam4.2649 · Cited by 29
U-Net and SegNet performances on lesion segmentation of breast ultrasonography images
Vianna, P., Farias, R., & Pereira, W. C. D. A. (2021) · Research on Biomedical Engineering · doi:10.1007/s42600-021-00137-4 · Cited by 29
Socioeconomic and Geographic Disparities in the Referral and Treatment of Pancreatic Cancer at High-Volume Centers
Sutton, T. L., Beneville, B., Johnson, A. J., Mayo, S. C., Gilbert, E. W., Lopez, C. D., Grossberg, A. J., Rocha, F. G., & Sheppard, B. C. (2022) · JAMA Surgery · doi:10.1001/jamasurg.2022.6709 · Cited by 28
Risk of Alzheimer’s Disease in Cancer Patients: Analysis of Mortality Data from the US SEER Population-Based Registries
Mezencev, R., & Chernoff, Y. O. (2020) · Cancers · doi:10.3390/cancers12040796 · Cited by 27
One Size Does Not Fit All: Marked Heterogeneity in Incidence of and Survival from Gastric Cancer among Asian American Subgroups
Huang, R. J., Sharp, N., Talamoa, R., Ji, H. P., Hwang, J. H., & Palaniappan, L. P. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-1482 · Cited by 27
Evaluating key characteristics of ideal colorectal cancer screening modalities: the microsimulation approach
Deibel, A., Deng, L., Cheng, C., Schlander, M., Ran, T., Lang, B. M., Krupka, N., Beerenwinkel, N., Rogler, G., Wiest, R., et al. (2021) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2021.02.013 · Cited by 26
Defining rurality: an evaluation of rural definitions and the impact on survival estimates
Franks, J. A., Davis, E., Bhatia, S., & Kenzik, K. M. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad031 · Cited by 26
Prognostic Model for Predicting Overall and Cancer-Specific Survival Among Patients With Cervical Squamous Cell Carcinoma: A SEER Based Study
Li, Z., Lin, Y., Cheng, B., Zhang, Q., & Cai, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.651975 · Cited by 25
Survival Differences in Chinese Versus White Women With Breast Cancer in the United States: A SEER-Based Analysis
Lim, D. W., Giannakeas, V., & Narod, S. A. (2020) · JCO Global Oncology · doi:10.1200/go.20.00316 · Cited by 24
The role of sex genotype in paediatric CNS tumour incidence and survival
Soon, W. C., Goacher, E., Solanki, S. P., Hayes, J. L., Kapetanstrataki, M., Picton, S. V., Chumas, P., & Mathew, R. K. (2021) · Child s Nervous System · doi:10.1007/s00381-021-05165-0 · Cited by 23
Development of a Machine Learning-Based Predictive Model for Lung Metastasis in Patients With Ewing Sarcoma
Li, W., Hong, T., Liu, W., Dong, S., Wang, H., Tang, Z., Li, W., Wang, B., Hu, Z., Liu, Q., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.807382 · Cited by 26
Racial Differences in Treatment and Survival among Veterans and Non-Veterans with Stage I NSCLC: An Evaluation of Veterans Affairs and SEER-Medicare Populations
Williams, C. D., Alpert, N., Redding, T. S., Bullard, A. J., Flores, R. M., Kelley, M. J., & Taioli, E. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0245 · Cited by 24
Association between socioeconomic status and survival in patients with hepatocellular carcinoma
Zheng, Y., Zhang, X., Lu, J., Liu, S., & Qian, Y. (2021) · Cancer Medicine · doi:10.1002/cam4.4223 · Cited by 24
Head and Neck Cancer Incidence in the United States Before and During the COVID-19 Pandemic
Semprini, J., Pagedar, N. A., Boakye, E. A., & Osazuwa‐Peters, N. (2024) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2023.4322 · Cited by 23
A SEER-based nomogram accurately predicts prognosis in Ewing’s sarcoma
Zhan, H., Mo, F., Zhu, M., Xu, X., Zhang, B., Liu, H., & Dai, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-02134-0 · Cited by 22
Should Endometrial Cancer Treatment Be Centralized?
Mandato, V. D., Palicelli, A., Torricelli, F., Mastrofilippo, V., Leone, C., Dicarlo, V., Tafuni, A., Santandrea, G., Annunziata, G., Generali, M., et al. (2022) · Biology · doi:10.3390/biology11050768 · Cited by 22
Precision information extraction for rare disease epidemiology at scale
Kariampuzha, W. Z., Alyea, G., Qu, S., Sanjak, J. S., Mathé, E. A., Sid, E., Chatelaine, H., Yadaw, A. S., Xu, Y., & Zhu, Q. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04011-y · Cited by 26
Persistence of data-driven knowledge to predict breast cancer survival
Kleinlein, R., & Riaño, D. (2019) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2019.06.018 · Cited by 22
Distant metastasis patterns among lung cancer subtypes and impact of primary tumor resection on survival in metastatic lung cancer using SEER database
Xie, T., Qiu, B.-M., Luo, J., Diao, Y., Hu, L., Liu, X., & Shen, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-73389-6 · Cited by 25
Clinicopathological characteristics and prognostic factors of pulmonary sarcomatoid carcinoma: a large population analysis
Gang, J., Yan, Q., Song, X., Zheng, L., & Zhao, L. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-6213 · Cited by 21
Use of the Decipher genomic classifier among men with prostate cancer in the United States
Zaorsky, N. G., Proudfoot, J. A., Jia, A. Y., Zuhour, R. J., Vince, R., Liu, Y., Zhao, X., Hu, J. C., Schussler, N. C., Stevens, J. L., et al. (2023) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkad052 · Cited by 21
Low-rank and sparse representation based learning for cancer survivability prediction
Yang, J., Ma, J., Win, K. T., Gao, J., & Yang, Z. (2021) · Information Sciences · doi:10.1016/j.ins.2021.10.013 · Cited by 20
Large Population Analysis of Secondary Cancers in Pediatric Leukemia Survivors
Yavvari, S., Makena, Y., Sukhavasi, S., & Makena, M. R. (2019) · Children · doi:10.3390/children6120130 · Cited by 20
Treatment and survival of primary intracranial germ cell tumors: a population-based study using SEER database
Denyer, S., Bhimani, A. D., Patil, S. N., Mudreac, A., Behbahani, M., & Mehta, A. I. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-03088-7 · Cited by 20
Marital status and survival of patients with colorectal signet ring cell carcinoma: a population-based study
Li, F., Yang, Y., Du, J., Yu, Y., & Diao, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-74720-7 · Cited by 21
Exploring the impact of PDGFD in osteosarcoma metastasis through single-cell sequencing analysis
Huang, Y., Cao, D., Zhang, M., Yang, Y., Niu, G., Tang, L., Shen, Z., Zhang, Z., Bai, Y., Min, D., et al. (2024) · Cellular Oncology · doi:10.1007/s13402-024-00949-3 · Cited by 20
Enhanced ovarian cancer survival prediction using temporal analysis and graph neural networks
Ghantasala, G. S. P., Dilip, K., Vidyullatha, P., Allabun, S. M., Alqahtani, M. S., Othman, M., Abbas, M. A. E., & Soufiene, B. O. (2024) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-024-02665-2 · Cited by 19
A survey on group fairness in federated learning: challenges, taxonomy of solutions and directions for future research
Salazar, T., Araújo, H. J., Cano, A., & Abreu, P. H. (2026) · Artificial Intelligence Review · doi:10.1007/s10462-025-11475-5 · Cited by 33
The revised staging system for malignant pleural mesothelioma based on surveillance, epidemiology, and end results database
Wang, S., Ma, K., Wang, Q., Sun, F., Shi, Y., Zhan, C., & Jiang, W. (2017) · International Journal of Surgery · doi:10.1016/j.ijsu.2017.10.034 · Cited by 19
A prognostic nomogram for overall survival in male breast cancer with histology of infiltrating duct carcinoma after surgery
Chai, X., Sun, M., Jia, H., Wang, M., Cao, L., Li, Z., & Wang, D.-W. (2019) · PeerJ · doi:10.7717/peerj.7837 · Cited by 19
Dietary Factors and Early-Onset Colorectal Cancer in the United States—an Ecologic Analysis
Chen, J., Zhang, I. L., Terry, M. B., & Yang, W. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-0442 · Cited by 19
Incidence and risk factors for suicide death in male patients with genital-system cancer in the United States
Yang, J., He, G., Chen, S., Pan, Z., Zhang, J., Li, Y., & Lyu, J. (2019) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2019.03.022 · Cited by 19
Geospatial analysis, web-based mapping and determinants of prostate cancer incidence in Georgia counties: evidence from the 2012–2016 SEER data
Aheto, J. M. K., Utuama, O. A., & Dagne, G. A. (2021) · BMC Cancer · doi:10.1186/s12885-021-08254-0 · Cited by 19
Development of machine learning model algorithm for prediction of 5‐year soft tissue myxoid liposarcoma survival
Kamalapathy, P. N., Ramkumar, D. B., Karhade, A. V., Kelly, S., Raskin, K. A., Schwab, J. H., & Lozano‐Calderón, S. A. (2021) · Journal of Surgical Oncology · doi:10.1002/jso.26398 · Cited by 19
Effectiveness of symptom monitoring on electronic patient-reported outcomes (ePROs) among patients with lung cancer: a systematic review and meta-analysis
Xia, Y., Guan, X., Zhu, W., Wang, Y., Shi, Z., & He, P. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01812-x · Cited by 19
Prognostic value of lymphatic vessel density in oral squamous cell carcinoma
Chen, J., Zhang, F., Hua, M., Song, X., Liu, S., & Dong, Z. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118746 · Cited by 18
Analysis of prognostic factors of undifferentiated pleomorphic sarcoma and construction and validation of a prediction nomogram based on SEER database
Wang, Z., Liu, J., Han, J., Yang, Z., & Wang, Q. (2022) · European journal of medical research · doi:10.1186/s40001-022-00810-z · Cited by 18
Development and validation of an XGBoost model to predict 5-year survival in elderly patients with intrahepatic cholangiocarcinoma after surgery: a SEER-based study
Xu, Q., & Lü, X. (2022) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-22-1238 · Cited by 18
Development and validation of a deep learning model for predicting postoperative survival of patients with gastric cancer
Wu, M., Yang, X., Liu, Y., Han, F., Li, X., Wang, J., Guo, D., Tang, X., Lü, L., & Liu, C. (2024) · BMC Public Health · doi:10.1186/s12889-024-18221-6 · Cited by 18
Using the “Hidden” genome to improve classification of cancer types
Chakraborty, S., Begg, C. B., & Shen, R. (2020) · Biometrics · doi:10.1111/biom.13367 · Cited by 17
Oncotype DX Breast Recurrence Score Distribution and Chemotherapy Benefit Among Women of Different Age Groups With HR-Positive, HER2-Negative, Node-Negative Breast Cancer in the SEER Database
Cheng, R., Kong, X., Wang, X., Fang, Y., & Wang, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01583 · Cited by 20
Application of Artificial Intelligence Methods to Pharmacy Data for Cancer Surveillance and Epidemiology Research: A Systematic Review
Grothen, A., Tennant, B., Wang, C., Torres, A. D., Sheppard, B. B., Abastillas, G., Matatova, M., Warner, J. L., & Rivera, D. R. R. (2020) · JCO Clinical Cancer Informatics · doi:10.1200/cci.20.00101 · Cited by 19
Racial and ethnic disparities in the refusal of surgical treatment in women 40 years and older with breast cancer in the USA between 2010 and 2017
Fwelo, P., Yusuf, Z. I., Adjei, A., Huynh, G., & Du, X. L. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06653-w · Cited by 17
Age-related differences in colon and rectal cancer survival by stage, histology, and tumour site: An analysis of United States SEER-18 data
Pilleron, S., Withrow, D. R., Nicholson, B. D., & Morris, E. J. A. (2023) · Cancer Epidemiology · doi:10.1016/j.canep.2023.102363 · Cited by 17

Authors: Duggan, M. A., Anderson, W. F., Altekruse, S., Penberthy, L., & Sherman, M. E.
Affiliations: University of Calgary (CA)
Division of Cancer Epidemiology and Genetics (US)
Cancer Control and Populations Sciences
National Cancer Institute (US)
Corresponding author: Duggan, Máire A.
ORCID: Duggan, Máire A.
Anderson, William F.
Altekruse, Sean
Penberthy, Lynne
Sherman, Mark E.
Venue: American Journal of Surgical Pathology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2016-12
Volume: 40
Issue: 12
Pages: e94-e102
ISSN: 0147-5185 (ISSN-L)
DOI: 10.1097/pas.0000000000000749
PMC: PMC5106320
OpenAlex: W2530755795
Cited by: 472
References: 46
Citations by year: 2026: 28 · 2025: 49 · 2024: 72 · 2023: 60 · 2022: 73 · 2021: 62 · 2020: 78 · 2019: 42 · 2018: 6 · 2017: 1
FWCI: 1.64
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: The American Journal of Surgical Pathology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (Z99 CA999999)
Topics: Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Cancer Diagnosis and Treatment
Keywords: cancer pathology, histological subtypes, molecular subtypes, driver mutations, cancer incidence, cancer survival, cancer mortality, biomarker data, cancer control
MeSH terms: Humans, Medical Oncology, Neoplasms, Pathology, Clinical, Biomarkers, Tumor, United States, SEER Program, Interdisciplinary Communication, Pathology, Molecular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: Toward Strengthening the Critical Relationship

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks